A Systematic Review and Network Meta-analysis of Randomized Data on Efficacy of Novel Therapy Combinations in Patients with Lenalidomide-refractory Multiple Myeloma Article (Faculty180)

cited authors

  • Mohyuddin, Ghulam Rehma R; Hampton, Jill; Aziz, Muhammad; Khuder, Sadik; Malik, Saad; McClune, Brian; Abdallah, Al-Ol O

description

  • Lenalidomide use in nearly all induction regimens for multiple myeloma (MM) has led to the treatment of lenalidomide-refractory disease becoming one of the most important clinical questions in its treatment. Given the lack of direct comparisons of treatment regimens for lenalidomide-refractory MM, we used a systematic review to identify randomized controlled trials (RCTs) that included lenalidomide-refractory subgroup analysis.

authors

publication date

  • 2021

published in

start page

  • 489

end page

  • 496

volume

  • 21